Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
Murat Beyazyüz,1 Tarkan Küfeciler,2 Leyla Bulut,3 Cüneyt Ünsal,1 Yakup Albayrak,1 Esra Soydaş Akyol,4 Saliha Baykal,1 Murat Kuloglu,5 Kenji Hashimoto61Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; 2Department of Emergency...
Guardado en:
Autores principales: | Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/373cdc0d13944cff8656b13517040848 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
por: Albayarak Y, et al.
Publicado: (2015) -
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal C, et al.
Publicado: (2013) -
Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function
por: Pan LH, et al.
Publicado: (2020) -
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
por: Akyol ES, et al.
Publicado: (2015) -
Minocycline as adjunct therapy for a male patient with deficit schizophrenia
por: Chen X, et al.
Publicado: (2018)